| __timestamp | ADMA Biologics, Inc. | Celldex Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 9517014 | 104381000 |
| Thursday, January 1, 2015 | 7015946 | 100171000 |
| Friday, January 1, 2016 | 7688238 | 102726000 |
| Sunday, January 1, 2017 | 6229587 | 96171000 |
| Monday, January 1, 2018 | 3926120 | 66449000 |
| Tuesday, January 1, 2019 | 2343848 | 42672000 |
| Wednesday, January 1, 2020 | 5907013 | 42534000 |
| Friday, January 1, 2021 | 3646060 | 53311000 |
| Saturday, January 1, 2022 | 3613764 | 82258000 |
| Sunday, January 1, 2023 | 3300000 | 118011000 |
Unleashing the power of data
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Celldex Therapeutics, Inc. has consistently outpaced ADMA Biologics, Inc. in R&D investment. From 2014 to 2023, Celldex's R&D expenses averaged around $80 million annually, peaking at $118 million in 2023. In contrast, ADMA's average annual R&D spending was approximately $5 million, with a high of $9.5 million in 2014. This stark difference highlights Celldex's aggressive pursuit of innovation, investing nearly 15 times more than ADMA in 2023 alone. As the biotech industry continues to evolve, these investment strategies could significantly impact each company's future growth and market position. Stay tuned to see how these financial commitments translate into groundbreaking therapies and market success.
Research and Development: Comparing Key Metrics for Johnson & Johnson and Celldex Therapeutics, Inc.
Research and Development Investment: AstraZeneca PLC vs Celldex Therapeutics, Inc.
R&D Spending Showdown: BeiGene, Ltd. vs Celldex Therapeutics, Inc.
R&D Insights: How Summit Therapeutics Inc. and ADMA Biologics, Inc. Allocate Funds
R&D Insights: How Exelixis, Inc. and Celldex Therapeutics, Inc. Allocate Funds
Halozyme Therapeutics, Inc. vs Celldex Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: Blueprint Medicines Corporation vs Celldex Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Grifols, S.A. and Celldex Therapeutics, Inc.
R&D Spending Showdown: Corcept Therapeutics Incorporated vs Celldex Therapeutics, Inc.
Analyzing R&D Budgets: ADMA Biologics, Inc. vs Amphastar Pharmaceuticals, Inc.
R&D Insights: How ADMA Biologics, Inc. and MiMedx Group, Inc. Allocate Funds
Comparing Innovation Spending: Celldex Therapeutics, Inc. and Viridian Therapeutics, Inc.